EIF3M and neoplasm: EIF3M expression was closely associated with poor patient prognosis, including reduced OS and DFS, as well as key biological processes such as genetic mutations, TMB, DNA methylation, miRNA regulatory networks, and remodeling of the tumor immune microenvironment.